Back

Histoindex's Stain-Free Digital Pathology System Receives HSA Approval for Liver Diagnosis

[The Straits Times and Multiple Coverage]

Designed to aid pathologists in the clinical diagnosis of liver fibrosis and other chronic liver diseases, the stain-free Laennec® digital pathology imaging system by MedTech innovator Histoindex Pte. Ltd. has achieved its first regulated in vitro diagnostics (IVD) product status with the issuance of a Health Sciences Authority (HSA) Class A licence. This is a world's first achievement for a stain-free digital pathology innovation to be approved for use in a clinical diagnosis setting.

Click here for the full scoop in The Straits Times.

 

The press release was featured in:

PR NewsWire

AsiaOne

Business Insider

BioSpectrum Asia

Tissue Pathology

Pharma Compass

Healthy Times

 

 

 

 

 

 

 

 

Back

Our site uses cookies or similar technologies to recognise your repeated visits and preferences for us to deliver an optimal browsing experience. Please remember to read our privacy statement.

By clicking on "I Accept" or "X" to continue your browsing on this site, you consent to the use of the cookies. To find out how you can disable cookies on your device, please click here.

I Accept